Having trouble accessing articles? Reset your cache.

Yeliva: Phase I data

Top-line data from an open-label, U.S. Phase I trial in 21 patients with advanced solid tumors

Read the full 165 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE